Involvement of a Calcineurin Cascade in Amygdala Depotentiation and Quenching of Fear Memory

  1. Chia-Ho Lin,
  2. Chia-Ching Lee and
  3. Po-Wu Gean
  1. Department of Pharmacology, College of Medicine, National Cheng-Kung University, Tainan, Taiwan
  1. Dr. Po-Wu Gean, Department of Pharmacology, College of Medicine, National Cheng-Kung University, Tainan, Taiwan 701. E-mail: powu{at}mail.ncku.edu.tw

Abstract

If fear memory is expressed by a long-term potentiation (LTP) of synaptic transmission in the amygdala, then reversal of LTP (depotentiation) in this area of the brain may provide an important mechanism for amelioration of anxiety and post-traumatic stress disorder. Herein, we show that low-frequency stimulation (LFS) of the external capsule elicits a depotentiation in the lateral nucleus of the amygdala. The induction of depotentiation requires activation ofN-methyl-d-aspartate receptors and voltage-dependent calcium channels but is independent of adenosine A1 and metabotropic glutamate group II receptors. Extracellular perfusion or loading cells with protein phosphatase (PP) 2B (calcineurin) inhibitors prevents depotentiation. The same stimulating protocol applied to the amygdala in vivo attenuates the expression of fear memory measured with fear-potentiated startle and reduces conditioning-elicited phosphorylation of Akt and mitogen-activated protein kinase (MAPK). This is paralleled by an increase in the activity of calcineurin. In addition, application of calcineurin inhibitor blocks LFS-induced extinction of fear memory and MAPK dephosphorylation. Taken together, this study characterizes the properties of LFS-induced depotentiation in the amygdala and suggests an involvement of calcineurin cascade in synaptic plasticity and memory storage.

Footnotes

  • This study was supported by National Science Council grant NSC89-2320-B006-011 and by Academic Excellence Program of the Ministry of Education grant 89-B-FA08-1-4, Taiwan, Republic of China.

  • Abbreviations:
    LTP
    long-term potentiation
    LFS
    low-frequency stimulation
    PP
    protein phosphatase
    EC
    external capsule
    NMDA
    N-methyl-d-aspartate
    VDCC
    voltage-dependent calcium channel
    LA
    lateral nucleus of amygdala
    MAPK
    mitogen-activated protein kinase
    ACSF
    artificial cerebrospinal fluid
    CS
    conditioned stimulus
    US
    unconditioned stimulus
    ERK
    extracellular signal-regulated kinase
    BLA
    basolateral amygdala
    FK-506
    tacrolimus
    TS
    tetanic stimulation
    fEPSP
    field excitatory postsynaptic potential
    d-APV
    d-2-amino-5-phosphonovaleate
    MK-801
    dizocilpine maleate
    DPCPX
    8-cyclopentyl-1,3-dipropylxanthine
    EGLU
    2S-α-ethylglutamic acid
    mGluR II
    metabotropic glutamate group II receptor
    AMPA
    α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
    GluR1
    glutamate receptor 1
    • Received April 30, 2002.
    • Accepted September 19, 2002.
« Previous | Next Article »Table of Contents